Affiliation:
1. Department of Chemistry CICECO – Aveiro Institute of Materials University of Aveiro Aveiro 3810‐193 Portugal
2. School of Biomedical Engineering Science, and Health Systems Drexel University 3141 Chestnut Street Philadelphia PA 19104 USA
3. CNC‐Center for Neurosciences and Cell Biology CIBB‐Center for Innovative Biomedicine and Biotechnology University of Coimbra Coimbra 3004‐517 Portugal
4. FMUC‐Faculty of Medicine University of Coimbra Coimbra 3004‐517 Portugal
Abstract
AbstractTherapeutic cells are usually administered as living agents, despite the risks of undesired cell migration and acquisition of unpredictable phenotypes. Additionally, most cell‐based therapies rely on the administration of single cells, often associated with rapid in vivo clearance. 3D cellular materials may be useful to prolong the effect of cellular therapies and offer the possibility of creating structural volumetric constructs. Here, the manufacturing of shape‐versatile fixed cell‐based materials with immunomodulatory properties is reported. Living cell aggregates with different shapes (spheres and centimeter‐long fibers) are fixed using a method compatible with maintenance of structural integrity, robustness, and flexibility of 3D constructs. The biological properties of living cells can be modulated before fixation, rendering an in vitro anti‐inflammatory effect toward human macrophages, in line with a decreased activation of the nuclear factor kappa B (NF‐κB) pathway that preponderantly correlated with the surface area of the materials. These findings are further corroborated in vivo in mouse skin wounds. Contact with fixed materials also reduces the proliferation of activated primary T lymphocytes, while promoting regulatory populations. The fixation of cellular constructs is proposed as a versatile phenotypic stabilization method that can be easily implemented to prepare immunomodulatory materials with therapeutic potential.
Funder
Division of Cancer Prevention, National Cancer Institute
Fundação para a Ciência e a Tecnologia
National Heart, Lung, and Blood Institute